Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Agenus Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
AGEN
Nasdaq
8731
https://agenusbio.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Agenus Inc
Acadia (ACAD) Begins Alzheimer's Disease Psychosis Study (Revised)
- Nov 30th, 2023 8:44 am
Avita (RCEL) Falls 19% on Lowered 2023 Revenue Guidance
- Nov 22nd, 2023 1:33 pm
Repare Therapeutics (RPTX) Rises 34% in a Week: Here's Why
- Nov 20th, 2023 1:19 pm
Rainbows and Unicorns: Agenus Inc. (NASDAQ:AGEN) Analysts Just Became A Lot More Optimistic
- Nov 9th, 2023 10:12 am
Agenus Inc (AGEN) Reports Q3 2023 Results: Revenue of $24.3 Million and Net Loss of $64.5 Million
- Nov 7th, 2023 11:55 am
Agenus Reports Third Quarter 2023 Results
- Nov 7th, 2023 11:30 am
Agenus to Provide Third Quarter 2023 Financial Report and Corporate Update
- Oct 26th, 2023 1:05 pm
Agenus Unveils New and Updated Botensilimab Data in Colorectal, Pancreatic, Lung, Melanoma, and Sarcoma
- Oct 22nd, 2023 4:00 pm
ESMO 2023: Agenus’ Botensilimab/Balstilimab Combination Delivers Durable Responses across Multiple Sarcoma Subtypes
- Oct 21st, 2023 8:15 am
Agenus Completes Enrollment in Randomized Phase 2 Clinical Trial of Botensilimab/Balstilimab in Advanced Colorectal Cancer
- Oct 10th, 2023 11:30 am
Agenus To Host BOT/BAL Program Update at ESMO 2023
- Oct 5th, 2023 11:30 am
Agenus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Sep 1st, 2023 8:30 pm
3 Magnificent Growth Stocks to Buy on the Dip
- Aug 28th, 2023 12:30 pm
Agenus to Participate in September Investor Conferences
- Aug 28th, 2023 11:30 am
Calculating The Intrinsic Value Of Agenus Inc. (NASDAQ:AGEN)
- Aug 28th, 2023 10:02 am
Agenus (AGEN) to Focus on BOT/BAL Candidate, Stock Falls 7%
- Aug 24th, 2023 1:54 pm
Watertown biotech shares spike after accidental data publication at Roche
- Aug 23rd, 2023 6:00 pm
Lexington biotech lays off 91 as it narrows focus
- Aug 23rd, 2023 5:16 pm
Agenus Prioritizes Resources to Accelerate Registration and Commercialization of BOT/BAL Program in Multiple Cancers
- Aug 23rd, 2023 12:00 pm
Q2 2023 Xilio Therapeutics Inc Earnings Call
- Aug 18th, 2023 8:27 am
Scroll